Matropin (Homatropine Hydrobromide)

Therapeutic Group : Mydriatic & Cycloplegic

Presentation:

Matropin Sterile Eye Drops: Each ml contains Homatropine Hydrobromide USP 20 mg.

Indications:

Matropin Sterile Eye Drops is indicated for use as a mydriatic and cycloplegic agent.

Dosage & Administration:

For refraction: Instill two drops in the eye(s) and repeat 2-3 times at 5-10 minute intervals. For therapy: Instill 1-2 drops in the eye(s) every 3-4 hours.

Contrainidications:

Contraindicated in patients with closed-angle glaucoma or with a narrow angle between the iris and the cornea.

Warning & Precautions:

Should be used with caution in patients with prostatic enlargement and in patients suffering from paralytic ileus or pyloric stenosis.

Side effects:

Hypersensitivity may occur as conjunctivitis.

Use in special groups:

Use in pregnancy: There are no adequate and well-controlled studies in pregnant women. Matropin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Use in lactation: It is not known whether Homatropine is excreted in human milk. Caution should be exercised when Matropin is administered to a nursing mother.

Use in children: Should not be used in children below the age of 3 months.

Packing:

Matropin Sterile Eye Drops: Each plastic dropper bottle contains 10 ml sterile eye drops.